|Day Low/High||308.47 / 318.81|
|52 Wk Low/High||291.69 / 442.00|
- EYLEA improves diabetic retinopathy and prevents worsening disease that can lead to blindness
Regeneron stock is under pressure after missing on earnings and revenue expectations. Are new lows on tap?
The company misses big on analysts bottom-line expectations.
Regeneron Pharmaceuticals revenue expected to rise 16.8% to $1.8 billion.
RMPIA outperformed once gain during April.
Jim Cramer looks at the investment strategies you and your family need to employ throughout your life.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Regeneron Pharmaceuticals, Inc. , where a total of 9,068 contracts have traded so far, representing approximately 906,800 underlying shares.
Netflix is bullish, but faces key resistance before it can make a big run higher.
A low-risk countertrend options trade may be worth a look in this name.
The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, and Regeneron Pharmaceuticals, Inc.
Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.
In this day and age, companies must be 'disruptors' or get left in the dust.
Top Award of $250,000 Goes to Ana Humphrey of Virginia in Nation's Oldest and Most Prestigious STEM Competition for High School Seniors
Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis
* Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.